Thursday 29 August 2013

13 Evidence-Based Medicinal Properties of Coconut Oil

13 Evidence-Based Medicinal Properties of Coconut Oil



While coconut oil has dragged itself out of the muck of vast misrepresentation over the past few years, it still rarely gets the appreciation it truly deserves. 

 Not just a "good" saturated fat, coconut oil is an exceptional healing agent as well, with loads of useful health applications.


read all athttp://www.greenmedinfo.com/blog/13-evidence-based-medicinal-properties-coconut-oil



10 Foods That Prevent Pimples And Irritated Skin – By Dr. Nayana P Hegde

Vitamin C lowers the harmful effects of air pollution, study finds

vitamin C
(NaturalNews) Vitamin C is one of the most important antioxidants on Earth, and its ability to aid tissue growth and repair is well-known. However, British researchers at the Imperial College of London have found another good reason to eat more oranges and lemons - vitamin C can also guard us against the negative effects of air pollutants such as car exhaust and power plants.

Learn more: http://www.naturalnews.com/041808_vitamin_C_harmful_effects_air_pollution.html#ixzz2dL2hBUkT

Thursday 22 August 2013

Bayer's Stivarga sets second OK in Japan

File:Regorafenib.svg
regorafenib
Bayer chalked up another approval for blockbuster-in-waiting Stivarga after Japan gave a green light for the drug's use in gastrointestinal stromal tumour (GIST).
This is the second approval for Stivarga (regorafenib) in Japan, having been cleared for the treatment of advanced or recurrent colorectal cancer in March. The product has already been approved for both indications in the US and is under review for the colorectal cancer indication in Europe

Tuesday 20 August 2013

Selexys Enrolls Sickle Cell Pain Trial

Selexys Pharmaceuticals Corporation, a privately held biopharmaceutical company that is developing therapies to treat inflammatory and thrombotic diseases, announced that enrollment has been initiated in SUSTAIN, a phase 2, multicenter, randomized, placebo-controlled, double-blind, 12-month study to assess safety and efficacy of the anti-P-selectin monoclonal antibody SelG1 with or without hydroxyurea therapy in sickle cell disease patients with sickle cell-related pain crises.

http://www.dddmag.com/news/2013/08/selexys-enrolls-sickle-cell-pain-trial?et_cid=3431535&et_rid=523035093&type=headline


Monday 12 August 2013

The Remarkable Healing Properties of Pumpkin Seed

The Remarkable Healing Properties of Pumpkin Seed

Pumpkin seeds, like all edible seeds, pack an immense nutritional  and medicinal punch. After all, they contain future worlds within their compact structure. As Emerson said, "the creation of a thousand forests is within one acorn."

In order to prepare their "babies.......................
read all at
http://www.greenmedinfo.com/blog/remarkable-healing-properties-pumpkin-seed

Tuesday 6 August 2013

Sanofi Pasteur Initiates Phase III Study of Investigational Clostridium difficile Vaccine in the United States

Cdiffense trial to evaluate vaccine against a leading cause of life-threatening, healthcare-associated infections worldwide
SWIFTWATER, Pa., Aug. 5, 2013 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwidehttp://www.pharmalive.com/sanofi-starts-phase-iii-trial-for-clostridium-difficile-vaccine

Monday 5 August 2013

Korean Cuisine to Burn Fat and Cholesterol

The search for a wonder drug that burns body fat and cholesterol leads to the Korean cuisine! Kochujang (KCJ), a fermented soybean-based red pepper paste, has been found to reduce body fat and improve blood lipid profile in overweight adults.
Korean Cuisine to Burn Fat and Cholesterol

Negligence of traditional dietary lifestyle can easily be linked to the prevalence of obesity and obesity-related chronic diseases. Kochujang (KCJ) has long been a part of seasonings in Korean cuisine as a sauce, dressi
Read more: Korean Cuisine to Burn Fat and Cholesterol | Medindia http://www.medindia.net/news/healthwatch/korean-cuisine-to-burn-fat-and-cholesterol-116141-1.htm#ixzz2b6BfqJOa
The search for a wonder drug that burns body fat and cholesterol leads to the Korean cuisine! Kochujang (KCJ), a fermented soybean-based red pepper paste, has been found to reduce body fat and improve blood lipid profile in overweight adults.

Negligence of traditional dietary lifestyle can easily be linked to the prevalence of obesity and obesity-related chronic diseases. Kochujang (KCJ) has long been a part of seasonings in Korean cuisine as a sauce, dressing or seasoning for meat, vegetable dishes, stew and soup. KCJ is a fermentation product of powdered red peppers combined with powdered meju (fermented soybean powder), salt, malt-digested rice syrup, and rice flour. It takes about six months for producing fermented KCJ.

Read more: Korean Cuisine to Burn Fat and Cholesterol | Medindia http://www.medindia.net/news/healthwatch/korean-cuisine-to-burn-fat-and-cholesterol-116141-1.htm#ixzz2b6BmVMr3

Garcinia Cambogia for Weight Loss

If you are an avid user of weight loss products or are interested in starting a diet then you may be curious about Garcinia Cambogia and how effective it is for weight loss. There is nothing worse than searching for information on weight loss products. Your search engine transforms from a helpful, information tool into a long ad that only links you to websites that are trying to sell you a product rather than actually give you any useful information. This is true whether or not the product is any good. Here are some facts on the weight loss product Garcinia Cambogia: it suppresses an enzyme known as citrate lyase and it increases serotonin levels in the brain.


img

Sunday 4 August 2013

Cinnamon's Infection and Diabetes-Fighting Properties Revealed

Cinnamon's Infection and Diabetes-Fighting Properties Revealed
Cinnamon's medicinal potential is as rich and complex as its flavor and aroma, with blood sugar balancing and infection fighting top on the list.
Cinnamon is a familiar spice, but few are aware of just how diverse are its medicinal properties.  TheUS National Library of Medicine houses well over 1300 abstracts on the subject of the various forms of cinnamon's potential health benefits.

Medicinal Herbs Show Ability to Replace Diabetes Medication without Side Effects

Medicinal Herbs Show Ability to Replace Diabetes Medication without Side Effects
Researchers from University of Mississippi's School of Pharmacy have conducted an extensive analysis of medicinal plants and proved once again that herbs can replace medications - now diabetes medications. They found that a number of herbs safely modulate cellular PPAR receptors – which means they help regulate glucose, insulin and fat metabolism.
The researchers screened extracts from a total of 263 species of herbs from 94 plant families. They found that eight of the extracts activated the PPARα (Peroxisome proliferator-activated receptor – alpha) and 22 of the plant extracts activated the PPARγ (Peroxisome proliferator-activated receptor – gamma).
Of these, five plant extracts activated both receptors. They were Daphine (Daphne gnidium), Star Anise (Illicium anisatum), Red Cedar (Juniperus virginiana), Haritaki (Terminalia chebula), and Thymelaea (Thymelaea hirsuta).
http://www.greenmedinfo.com/blog/medicinal-herbs-show-ability-replace-diabetes-medication-without-side-effects

Saturday 3 August 2013

MICROENCAPSULATION: ADVANCEMENTS IN TECHNOLOGY AND ITS PATENTS



Microcapsule is a tiny sphere including core material/internal phase or fill, coated with/surrounded by wall know as shell, coating or membrane. The usual size range of the microcapsule lies between 1 to 1000 μm. The technique is usually applied for targeted drug delivery, protection of the molecule and stability if the core material. Microencapsulation system offers potential advantages over conventional drug delivery systems and also established as unique carrier systems for many pharmaceuticals. This article contains the traditional and the recent techniques, including their patents, for the preparation of microcapsules. Solvent exchange method, coacervation, polymerization, hot melts etc are several recent techniques are used for the preparation of the microcapsules. The microencapsulation technique, as Novel drug Delivery System (NDDS), is widely applied for delivery of probiotics, drugs, pesticide, food etc. Although significant advances have been made in the field of microencapsulation, still many challenges need to be rectified during the appropriate selection of core materials, coating materials and process techniques.... read all at
http://www.pharmatutor.org/articles/microencapsulation-advancements-technology-patents

................... .................

Thursday 1 August 2013

Alexza Pharmaceuticals Announces European Launch of ADASUVE® (Staccato® Loxapine)



LOXAPINE

MOUNTAIN VIEW, Calif., July 30, 2013 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (ALXA) today announced that the company's commercial partner Grupo Ferrer Internacional, S.A. has initiated sales of ADASUVE® inhalation powder, pre-dispensed (Staccato® Loxapine) in the European Union ("EU").  ADASUVE is now available in Germany.  The first sale and shipment of product by Ferrer triggers a $1.25 million milestone payment to Alexza, pursuant to the Company's collaboration agreement with Ferrer.

http://finance.yahoo.com/news/alexza-pharmaceuticals-announces-european-launch-130000571.html


Loxapine (LoxapacLoxitane) is a typical antipsychotic medication, used primarily in the treatment of schizophrenia. It is a member of the dibenzoxazepine class and structurally related to clozapine (which belongs to the chemically akin class ofdibenzodiazepines). Several researchers have argued that Loxapine may behave as an atypical antipsychotic.
Loxapine may be metabolized by N-demethylation to amoxapine, a tetracyclic antidepressant





Schmutz, J.; Kunzle, F.; Hunziker, F.; Gauch, R.; Helv. Chim. Acta 1967, 50, 245.